Insider Transactions in Q4 2017 at Dicerna Pharmaceuticals Inc (DRNA)
Insider Transaction List (Q4 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2017
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,645,442
+34.27%
|
-
|
|
Dec 18
2017
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
190,849
+2.09%
|
-
|
|
Dec 18
2017
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,454,388
+49.17%
|
-
|
|
Dec 18
2017
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
285,000
+50.0%
|
$1,995,000
$7.0 P/Share
|